You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Parvovirus B19

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parvovirus B19 Infection in Hereditary Hemolytic Anemias

Active, not recruiting
  • Parvovirus B19 Infection
  • Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG)
  • Sohag, Egypt
    , Faculty of Medicine, Sohag University
Mar 25, 2021

COVID-19, Influenza A, Influenza B Trial in Vienna (Panbio™)

Recruiting
  • COVID-19
  • +2 more
  • Panbio™
  • Vienna, Virginia
    Advanced Pediatrics
Nov 17, 2023

COVID-19, Influenza A, Influenza Type B Trial in Pelham, Brooklyn (Panbio™ COVID-19/Flu A&B Panel)

Recruiting
  • COVID-19
  • +2 more
  • Panbio™ COVID-19/Flu A&B Panel
  • Pelham, Alabama
  • +1 more
Nov 10, 2023

Influenza A, Influenza Type B, Coronavirus Disease 2019 Trial in Ballarat (LIAISON NES FLU A/B & COVID-19)

Not yet recruiting
  • Influenza A
  • +2 more
  • LIAISON NES FLU A/B & COVID-19
  • Ballarat, Victoria, Australia
    Grampians Health
Jun 7, 2023

Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • RC19D2 cell injection
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 14, 2023

B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

Recruiting
  • B-Cell Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2023

COVID-19, Influenza A, Influenza Type B Trial in Easley (Panbio™)

Recruiting
  • COVID-19
  • +2 more
  • Panbio™
  • Easley, South Carolina
    UCCT @ AFC Urgent Care- Easley
Feb 3, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

COVID-19, Influenza A, Influenza B Trial in Miami (MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B

Recruiting
  • COVID-19
  • +2 more
  • MGC Health COVID-19 & Flu A+B Home Multi Test
  • MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)
  • Miami, Florida
    L&A Morales Healthcare
Feb 15, 2023

B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • (no location specified)
Oct 10, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Diffuse Large B Cell Lymphoma
  • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Nov 19, 2023

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (Pirtobrutinib, LV20.19 CAR T cells)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • (no location specified)
Aug 4, 2023

Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Metabolically Armed CD19 CAR-T cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Nov 1, 2023

Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

Recruiting
  • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
  • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
  • ELISA and colorimeter
  • Assiut, Egypt
    Biochemistry department,Faculty of medicine
Oct 10, 2023

B-cell NHL, CLL Trial (CARCIK-CD19)

Not yet recruiting
  • B-cell NHL
  • CLL
  • CARCIK-CD19
  • (no location specified)
May 19, 2023

COVID-19 Infection and Its Clinical Prognosis in Chronic

Recruiting
  • Chronic Hepatitis B
  • COVID-19 Infection
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

B-Cell Leukemia, B-Cell Lymphoma, B-cell Tumors Trial in Kunming (Anti-CD19 Autologous CAR-T Cell Infusion)

Recruiting
  • B-Cell Leukemia
  • +2 more
  • Anti-CD19 Autologous CAR-T Cell Infusion
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Jul 9, 2023

COVID-19 Trial in Taipei (Ropeginterferon alfa-2b, SOC)

Not yet recruiting
  • COVID-19
  • Ropeginterferon alfa-2b
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 9, 2023

B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

Recruiting
  • B-Cell Lymphoma
  • +4 more
  • 19(T2)28z1xx TRAC T cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 24, 2023

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (Metabolically Armed CD19 CAR-T cells)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Metabolically Armed CD19 CAR-T cells
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Feb 17, 2023

COVID-19 Trial in Taipei (P1101 (Ropeginterferon alfa-2b), SOC)

Active, not recruiting
  • COVID-19
  • P1101 (Ropeginterferon alfa-2b)
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Mar 13, 2023

Refractory or Relapsed B Cell Lymphoma Trial in Chongqing (ThisCART19A, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Refractory or Relapsed B Cell Lymphoma
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 8, 2023